Compare · EW vs WLFC
EW vs WLFC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Willis Lease Finance Corporation (WLFC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while WLFC operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $52.38B, about 45.4x WLFC ($1.15B).
- WLFC has been more active in the news (12 items in the past 4 weeks vs 3 for EW).
- EW has more recent analyst coverage (25 ratings vs 0 for WLFC).
- Company
- Edwards Lifesciences Corporation
- Willis Lease Finance Corporation
- Price
- -
- -
- Market cap
- $52.38B
- $1.15B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 1996
- News (4w)
- 3
- 12
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Willis Lease Finance Corporation
Willis Lease Finance Corporation operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. The company operates through two segments, Leasing and Related Operations, and Spare Parts Sales. The Leasing and Related Operations segment engages in acquiring and leasing commercial aircraft, aircraft engines, and other aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and other related businesses. The Spare Parts Sales segment purchases and resells after-market engine parts, whole engines, engine modules, and portable aircraft components. Willis Lease Finance Corporation was founded in 1985 and is headquartered in Coconut Creek, Florida.
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
Latest WLFC
- Willis Lease Finance Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits
- Willis Lease Finance Corporation Closes Transaction to Acquire Commercial Aircraft and Aircraft Engine Portfolio
- Executive Chairman Willis Charles F Iv sold $2,535,677 worth of shares (46,500 units at $54.53) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,519,143 units (SEC Form 4)
- Executive Chairman Willis Charles F Iv sold $4,478,279 worth of shares (78,200 units at $57.27) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 2,565,643 units (SEC Form 4)
- Willis Lease Finance Corporation CEO Austin C. Willis to Speak at Deutsche Bank's 16th Annual Aviation Forum
- SVP, GC & Corporate Secretary Dameron Clifton sold $200,894 worth of shares (3,535 units at $56.83), decreasing direct ownership by 8% to 39,458 units (SEC Form 4)
- Willis Lease Finance Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement
- President and CEO Willis Austin Chandler sold $1,100,103 worth of shares (15,000 units at $73.34) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 435,888 units (SEC Form 4)
- SEC Form 10-Q filed by Willis Lease Finance Corporation
- Willis Lease Finance Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits